Elevated serum visfatin levels are associated with poor prognosis of hepatocellular carcinoma-Reference-Cited by-同舟云学术

Elevated serum visfatin levels are associated with poor prognosis of hepatocellular carcinoma

Published:2017-02-04 Issue:14 Volume:8 Page:23427-23435
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Sun Yifan¹,Zhu Shengbo²,Wu Zhitong³,Huang Yiyong²,Liu Chunming²,Tang Shifu²,Wei Lili⁴

Affiliation:

1. Department of Clinical Laboratory, Affiliated Liutie Central Hospital of Guangxi Medical University, Liuzhou, Guangxi, China

2. Department of Clinical Laboratory, Third Affiliated Hospital of Guangxi University of Chinese Medicine, Liuzhou, Guangxi, China

3. Department of Clinical Laboratory, Eighth Affiliated Hospital of Guangxi Medical University, Guigang City People's Hospital, Guigang, Guangxi, China

4. Department of Science and Education, Third Affiliated Hospital of Guangxi University of Chinese Medicine, Liuzhou, Guangxi, China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biomarkers in Cerebrospinal Fluid for the Diagnosis and Monitoring of Gliomas;Biomolecules;2024-07-05

2. Visfatin Facilitates VEGF-D-Induced Lymphangiogenesis through Activating HIF-1α and Suppressing miR-2277-3p in Human Chondrosarcoma;International Journal of Molecular Sciences;2024-05-09

3. Targeting NAD+ metabolism: dual roles in cancer treatment;Frontiers in Immunology;2023-12-05

4. Extracellular nicotinamide phosphoribosyltransferase: role in disease pathophysiology and as a biomarker;Frontiers in Immunology;2023-10-17

5. Visfatin upregulates VEGF-C expression and lymphangiogenesis in esophageal cancer by activating MEK1/2-ERK and NF-κB signaling;Aging;2023-06-07